{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T01:17:04Z","timestamp":1792459024319,"version":"4.5.0"},"reference-count":30,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,5,8]],"date-time":"2023-05-08T00:00:00Z","timestamp":1683504000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Adrenal incidentalomas with cortisol autonomy are associated with increased cardiovascular morbidity and mortality. Specific data on the clinical and biochemical course of affected patients are lacking.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Retrospective study from a tertiary referral centre in Germany. After exclusion of overt hormone excess, malignancy and glucocorticoid medication, patients with adrenal incidentalomas were stratified according to serum cortisol after 1 mg dexamethasone: autonomous cortisol secretion (ACS), &amp;gt;5.0; possible ACS (PACS), 1.9-5.0; non-functioning adenomas (NFA), \u22641.8 \u00b5g\/dl.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>A total of 260 patients were enrolled (147 women (56.5%), median follow-up 8.8 (2.0-20.8) years). At initial diagnosis, median age was 59.5 (20-82) years, and median tumour size was 27 (10-116) mm. Bilateral tumours were more prevalent in ACS (30.0%) and PACS (21.9%) than in NFA (8.1%). Over time, 40\/124 (32.3%) patients had a shift of their hormonal secretion pattern (NFA to PACS\/ACS, n=15\/53; PACS to ACS, n=6\/47; ACS to PACS, n=11\/24; PACS to NFA, n=8\/47). However, none of the patients developed overt Cushing\u2019s syndrome. Sixty-one patients underwent adrenalectomy (NFA, 17.9%; PACS, 24.0%; ACS, 39.0%). When non-operated patients with NFA were compared to PACS and ACS at last follow-up, arterial hypertension (65.3% vs. 81.9% and 92.0%; p&amp;lt;0.05), diabetes (23.8% vs. 35.6% and 40.0%; p&amp;lt;0.01), and thromboembolic events (PACS: HR 3.43, 95%-CI 0.89-13.29; ACS: HR 5.96, 95%-CI 1.33-26.63; p&amp;lt;0.05) were significantly less frequent, along with a trend towards a higher rate of cardiovascular events in case of cortisol autonomy (PACS: HR 2.23, 95%-CI 0.94-5.32; ACS: HR 2.60, 95%-CI 0.87-7.79; p=0.1). Twenty-five (12.6%) of the non-operated patients died, with higher overall mortality in PACS (HR 2.6, 95%-CI 1.0-4.7; p=0.083) and ACS (HR 4.7, 95%-CI 1.6-13.3; p&amp;lt;0.005) compared to NFA. In operated patients, prevalence of arterial hypertension decreased significantly (77.0% at diagnosis to 61.7% at last follow-up; p&amp;lt;0.05). The prevalence of cardiovascular events and mortality did not differ significantly between operated and non-operated patients, whereas thromboembolic events were significantly less frequent in the surgical treatment group.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Our study confirms relevant cardiovascular morbidity in patients with adrenal incidentalomas (especially those with cortisol autonomy). These patients should therefore be monitored carefully, including adequate treatment of typical cardiovascular risk factors. Adrenalectomy was associated with a significantly decreased prevalence of hypertension. However, more than 30% of patients required reclassification according to repeated dexamethasone suppression tests. Thus, cortisol autonomy should ideally be confirmed before making any relevant treatment decision (e.g. adrenalectomy).<\/jats:p><\/jats:sec>","DOI":"10.3389\/fendo.2023.1123132","type":"journal-article","created":{"date-parts":[[2023,5,8]],"date-time":"2023-05-08T04:47:08Z","timestamp":1683521228000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":19,"title":["Clinical course of patients with adrenal incidentalomas and cortisol autonomy: a German retrospective single center cohort study"],"prefix":"10.3389","volume":"14","author":[{"given":"Hanna","family":"Remde","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefanie","family":"Kranz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah Maria","family":"Morell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Altieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Kroiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Detomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Fassnacht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timo","family":"Deutschbein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,5,8]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"G1","DOI":"10.1530\/EJE-16-0467","article-title":"Management of adrenal incidentalomas: European society of endocrinology clinical practice guideline in collaboration with the European network for the study of adrenal tumors","volume":"175","author":"Fassnacht","year":"2016","journal-title":"Eur J Endocrinol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/s2213-8587(22)00100-0","article-title":"Age-dependent and sex-dependent disparity in mortality in patients with adrenal incidentalomas and autonomous cortisol secretion: An international, retrospective, cohort study","volume":"10","author":"Deutschbein","year":"2022","journal-title":"Lancet Diabetes Endocrinol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-016-1017-3","article-title":"Six controversial issues on subclinical cushing's syndrome","volume":"56","author":"Chiodini","year":"2017","journal-title":"Endocrine"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.2011.04253.x","article-title":"Subclinical cushing's syndrome: Definition and management","volume":"76","author":"Terzolo","year":"2012","journal-title":"Clin Endocrinol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1007\/s00108-021-01188-6","article-title":"[Autonomous cortisol secretion : Laboratory artifact or disease?]","volume":"63","author":"Riester","year":"2022","journal-title":"Internist"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.7326\/M20-7946","article-title":"Association between mortality and levels of autonomous cortisol secretion by adrenal incidentalomas : A cohort study","volume":"174","author":"Kjellbom","year":"2021","journal-title":"Ann Intern Med"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.7326\/M21-1737","article-title":"Cardiometabolic disease burden and steroid excretion in benign adrenal tumors : A cross-sectional multicenter study","volume":"175","author":"Prete","year":"2022","journal-title":"Ann Intern Med"},{"key":"B8","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1016\/S2213-8587(13)70211-0","article-title":"Cardiovascular events and mortality in patients with adrenal incidentalomas that are either non-secreting or associated with intermediate phenotype or subclinical cushing's syndrome: A 15-year retrospective study","volume":"2","author":"Di Dalmazi","year":"2014","journal-title":"Lancet Diabetes Endocrinol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2014-3007","article-title":"Cortisol as a marker for increased mortality in patients with incidental adrenocortical adenomas","volume":"99","author":"Debono","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-017-1400-8","article-title":"Increased mortality in patients with adrenal incidentalomas and autonomous cortisol secretion: A 13-year retrospective study from one center","volume":"58","author":"Patrova","year":"2017","journal-title":"Endocrine"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-16-0465","article-title":"Therapy of endocrine disease: Improvement of cardiovascular risk factors after adrenalectomy in patients with adrenal tumors and subclinical cushing's syndrome: A systematic review and meta-analysis","volume":"175","author":"Bancos","year":"2016","journal-title":"Eur J Endocrinol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-12-0777","article-title":"Bilateral and unilateral adrenal incidentalomas: Biochemical and clinical characteristics","volume":"168","author":"Morelli","year":"2013","journal-title":"Eur J Endocrinol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1530\/EJE-13-0848","article-title":"Bilateral adrenal incidentalomas differ from unilateral adrenal incidentalomas in subclinical cortisol hypersecretion but not in potential clinical implications","volume":"171","author":"Vassilatou","year":"2014","journal-title":"Eur J Endocrinol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1210\/endrev\/bnaa008","article-title":"Adrenal incidentaloma","volume":"41","author":"Sherlock","year":"2020","journal-title":"Endocr Rev"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1097\/SLA.0b013e31819a47d2","article-title":"Surgical versus conservative management for subclinical cushing syndrome in adrenal incidentalomas: A prospective randomized study","volume":"249","author":"Toniato","year":"2009","journal-title":"Ann Surg"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.898084","article-title":"Adrenalectomy improves blood pressure and metabolic control in patients with possible autonomous cortisol secretion: Results of a rct","volume":"13","author":"Morelli","year":"2022","journal-title":"Front Endocrinol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1002\/bjs.9742","article-title":"Systematic review of surgical treatment of subclinical cushing's syndrome","volume":"102","author":"Iacobone","year":"2015","journal-title":"Br J Surg"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1007\/PL00012314","article-title":"Laparoscopic adrenalectomy: New gold standard","volume":"23","author":"Smith","year":"1999","journal-title":"World J Surg"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2009-2387","article-title":"Beneficial metabolic effects of prompt surgical treatment in patients with an adrenal incidentaloma causing biochemical hypercortisolism","volume":"95","author":"Chiodini","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1507\/endocrj.K07E-177","article-title":"Cardiovascular risks and their long-term clinical outcome in patients with subclinical cushing's syndrome","volume":"55","author":"Tsuiki","year":"2008","journal-title":"Endocrine J"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-09-0234","article-title":"Recommended evaluation of adrenal incidentalomas is costly, has high false-positive rates and confers a risk of fatal cancer that is similar to the risk of the adrenal lesion becoming malignant; time for a rethink","volume":"161","author":"Cawood","year":"2009","journal-title":"Eur J Endocrinol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.7326\/M18-3630","article-title":"Natural history of adrenal incidentalomas with and without mild autonomous cortisol excess: A systematic review and meta-analysis","volume":"171","author":"Elhassan","year":"2019","journal-title":"Ann Intern Med"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2016-1586","article-title":"Genetic landscape of sporadic unilateral adrenocortical adenomas without PRKACA p.Leu206Arg mutation","volume":"101","author":"Ronchi","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgaa616","article-title":"Rna sequencing and somatic mutation status of adrenocortical tumors: Novel pathogenetic insights","volume":"105","author":"Di Dalmazi","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgab682","article-title":"Targeted mutational analysis of cortisol-producing adenomas","volume":"107","author":"Rege","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(14)61375-1","article-title":"Cushing's syndrome","volume":"386","author":"Lacroix","year":"2015","journal-title":"Lancet"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1310359","article-title":"Constitutive activation of pka catalytic subunit in adrenal cushing's syndrome","volume":"370","author":"Beuschlein","year":"2014","journal-title":"N Engl J Med"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1111\/cen.13294","article-title":"Concomitant alterations of metabolic parameters, cardiovascular risk factors and altered cortisol secretion in patients with adrenal incidentalomas during prolonged follow-up","volume":"86","author":"Papanastasiou","year":"2017","journal-title":"Clin Endocrinol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1007\/s40618-016-0558-x","article-title":"Follow-up of patients with adrenal incidentaloma, in accordance with the European society of endocrinology guidelines: Could we be safe","volume":"40","author":"Morelli","year":"2017","journal-title":"J Endocrinol Invest"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1055\/a-1079-4915","article-title":"Clinical characteristics and follow-up results of adrenal incidentaloma","volume":"129","author":"Yilmaz","year":"2020","journal-title":"Exp Clin Endocrinol Diabetes"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2023.1123132\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,8]],"date-time":"2023-05-08T04:47:12Z","timestamp":1683521232000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2023.1123132\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,8]]},"references-count":30,"alternative-id":["10.3389\/fendo.2023.1123132"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2023.1123132","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,8]]},"article-number":"1123132"}}